Paradox Immunotherapeutics Incorporated
$183,595.00 CAD
≈ 2 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- January 11, 2023 – April 30, 2024
- Reference
- nrc-cnrc:172-2022-2023-Q4-1003392
Published purpose
Identification, characterization, and screening of monoclonal antibodies for the treatment of ? and ?-light chain amyloidosis and drug discovery for ALECT2 amyloidosis. Potential candidates will be screened for in vitro binding affinity and specificity and for in vivo activity in cell and small animal models.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions